Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy

被引：0
|
作者：
Shengzhe Jin
Hongfei Wang
Yang Li
Jingwen Yang
Beibei Li
Peishang Shi
Xiangrui Zhang
Xiaowen Zhou
Xiuman Zhou
Xiaoshuang Niu
Menghan Wu
Yahong Wu
Wenjie Zhai
Yuanming Qi
Yanfeng Gao
Wenshan Zhao
机构：
[1] Zhengzhou University,School of Life Sciences
[2] Xinxiang Medical University,Henan Key Laboratory of Immunology and Targeted Drugs, School of Medical Technology
[3] Shenzhen Campus of Sun Yat-Sen University,School of Pharmaceutical Sciences (Shenzhen)
[4] Zhengzhou University,International Joint Laboratory for Protein and Peptide Drugs of Henan Province
来源：
Cell Communication and Signaling | / 22卷
关键词：
Tumor microenvironment; Immune checkpoint blockade; PD-1/PD-L1; CD47/SIRPα; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
    Jin, Shengzhe
    Wang, Hongfei
    Li, Yang
    Yang, Jingwen
    Li, Beibei
    Shi, Peishang
    Zhang, Xiangrui
    Zhou, Xiaowen
    Zhou, Xiuman
    Niu, Xiaoshuang
    Wu, Menghan
    Wu, Yahong
    Zhai, Wenjie
    Qi, Yuanming
    Gao, Yanfeng
    Zhao, Wenshan
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [2] Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
    Hu, Zheng
    Li, Wanqiong
    Chen, Shaomeng
    Chen, Danhong
    Xu, Ran
    Zheng, Danlu
    Yang, Xin
    Li, Shuzhen
    Zhou, Xiuman
    Niu, Xiaoshuang
    Xiao, Youmei
    He, Zhuoying
    Li, Huihao
    Liu, Juan
    Sui, Xinghua
    Gao, Yanfeng
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (10) : 2310 - 2328
  • [3] Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
    Zheng Hu
    Wanqiong Li
    Shaomeng Chen
    Danhong Chen
    Ran Xu
    Danlu Zheng
    Xin Yang
    Shuzhen Li
    Xiuman Zhou
    Xiaoshuang Niu
    Youmei Xiao
    Zhuoying He
    Huihao Li
    Juan Liu
    Xinghua Sui
    Yanfeng Gao
    Science China(Life Sciences) , 2023, (10) : 2310 - 2328
  • [4] Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
    Zheng Hu
    Wanqiong Li
    Shaomeng Chen
    Danhong Chen
    Ran Xu
    Danlu Zheng
    Xin Yang
    Shuzhen Li
    Xiuman Zhou
    Xiaoshuang Niu
    Youmei Xiao
    Zhuoying He
    Huihao Li
    Juan Liu
    Xinghua Sui
    Yanfeng Gao
    Science China Life Sciences, 2023, 66 : 2310 - 2328
  • [5] Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy
    Zheng Hu
    Wanqiong Li
    Shaomeng Chen
    Danhong Chen
    Ran Xu
    Danlu Zheng
    Xin Yang
    Shuzhen Li
    Xiuman Zhou
    Xiaoshuang Niu
    Youmei Xiao
    Zhuoying He
    Huihao Li
    Juan Liu
    Xinghua Sui
    Yanfeng Gao
    Science China(Life Sciences), 2023, 66 (10) : 2310 - 2328
  • [6] Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
    Xu, Yongling
    Du, Huijie
    Guo, Weibo
    Liu, Beibei
    Yan, Wenxin
    Zhang, Chi
    Qin, Long
    Huang, Jingling
    Wang, Hongxia
    Wu, Shiqi
    Ren, Weijie
    Zou, Yi
    Wang, Jie
    Zhu, Qihua
    Xu, Yungen
    Gu, Hongfeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 4083 - 4099
  • [7] Novel, small molecule inhibitors of PD-1/PD-L1 pathway
    Rastelli, Luca
    Rajagopal, Sridharan
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohd, Zainuddin
    Gosu, Ramachandraiah
    Friedmann-Morvinski, Dinorah
    Kandan, Saravanan
    Birudukota, Swarnakumari
    Srinivasan, S.
    Krishnakumar, V
    Wahid, Saif
    Siddiqui, Amir
    Viswakarma, Santosh
    Narayan, Ashwini
    Rudresh, G.
    Mullurwar, Sadanand R.
    Sher, Divsha
    Mansur, Shahar
    Sivanandhan, Dhanalakshmi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Novel, small molecule PD-L1 inhibitors for cancer immunotherapy
    Sivanandhan, D.
    Garapaty, S.
    Seerapu, G. P.
    Das, R.
    Kar, R.
    Singh, A. K.
    Kumar, V. Ashok
    Venkateshappa, C.
    Putta, R.
    Pendyala, M.
    Jadhav, T.
    Wani, A. E.
    Ghanta, S.
    Birudukota, S.
    Gogoi, H.
    Nadig, H.
    Gangaiah, R.
    Mohd, Z.
    Athisayamani, J.
    Rajagopal, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E79 - E79
  • [9] Small-molecule inhibitor PD-1 /PD-L1 interaction for colorectal cancer treatment
    Anaya-Ruiz, Maricruz
    Perez-Santos, Martin
    PHARMACEUTICAL PATENT ANALYST, 2021, 10 (06) : 245 - 250
  • [10] Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy
    Zhai, Wenjie
    Zhou, Xiuman
    Zhai, Mingxia
    Li, Wanqiong
    Ran, Yunhui
    Sun, Yixuan
    Du, Jiangfeng
    Zhao, Wenshan
    Xing, Lingxiao
    Qi, Yuanming
    Gao, Yanfeng
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 548 - 562
12345